Efficacy and Safety of a Fixed-Dose Combination of Indacaterol and Glycopyrronium for the Treatment of COPD

Article ID	Journal	Published Year	Pages	File Type
5954833	Chest	2014	9 Pages	PDF

Abstract

Once-daily, inhaled QVA149 showed superior efficacy compared with glycopyrronium and the current standard of care, tiotropium, in patients with moderate to severe COPD.

Keywords

TDI QVA149 MCID SAE SGRQ Minimal clinical important difference NNTB LAMA long-acting muscarinic antagonist Long-acting β2-agonist LABA Transition dyspnea index adverse event Serious adverse event St. George's Respiratory Questionnaire